Page last updated: 2024-11-04

succinylacetone and Disease Exacerbation

succinylacetone has been researched along with Disease Exacerbation in 2 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Research Excerpts

ExcerptRelevanceReference
"ABCB6 expression is upregulated in hepatocellular carcinoma (HCC) but the significance of this upregulation to HCC is not known."1.37Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma. ( Abdulkarim, BA; Chavan, H; Krishnamurthy, P; Polireddy, K, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polireddy, K1
Chavan, H1
Abdulkarim, BA1
Krishnamurthy, P1
Pierik, LJ1
van Spronsen, FJ1
Bijleveld, CM1
van Dael, CM1

Other Studies

2 other studies available for succinylacetone and Disease Exacerbation

ArticleYear
Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.
    Molecular oncology, 2011, Volume: 5, Issue:5

    Topics: ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation;

2011
Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; Glomerular Filt

2005